BSE Live
Oct 01, 16:01Prev. Close
1126.00
Open Price
1126.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 01, 15:44Prev. Close
1127.70
Open Price
1123.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
Profit & Loss account of SMS Lifesciences India (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 333.37 | 326.24 | 350.76 | 376.59 | 278.50 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 28.30 | 36.46 | 33.40 | 26.37 | |
Revenue From Operations [Net] | 333.37 | 297.94 | 314.30 | 343.19 | 252.12 | |
Total Operating Revenues | 333.37 | 300.00 | 315.24 | 345.63 | 260.26 | |
Other Income | 3.95 | 3.84 | 2.88 | 1.54 | 1.33 | |
Total Revenue | 337.32 | 303.84 | 318.12 | 347.16 | 261.59 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 164.43 | 161.19 | 189.95 | 216.16 | 137.76 | |
Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Operating And Direct Expenses | 0.00 | 50.53 | 49.58 | 58.32 | 46.66 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | 4.69 | 0.98 | 0.30 | -7.79 | 1.90 | |
Employee Benefit Expenses | 45.78 | 37.94 | 34.72 | 32.51 | 27.11 | |
Finance Costs | 7.88 | 8.90 | 5.09 | 4.63 | 4.50 | |
Depreciation And Amortisation Expenses | 10.26 | 10.25 | 8.17 | 7.99 | 7.21 | |
Other Expenses | 74.24 | 14.94 | 14.28 | 15.05 | 17.09 | |
Total Expenses | 307.28 | 284.73 | 302.10 | 326.88 | 242.23 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 30.04 | 19.11 | 16.02 | 20.28 | 19.35 | |
Exceptional Items | 0.00 | 0.00 | 2.35 | 12.69 | 0.00 | |
Profit/Loss Before Tax | 30.04 | 19.11 | 18.37 | 32.98 | 19.35 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 8.67 | 4.25 | 3.50 | 8.50 | 5.25 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 0.00 | 1.99 | 2.01 | 0.04 | 1.16 | |
Tax For Earlier Years | 0.00 | -0.20 | -0.35 | -0.94 | -0.22 | |
Total Tax Expenses | 8.67 | 6.05 | 5.15 | 7.60 | 6.19 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 21.37 | 13.07 | 13.22 | 25.38 | 13.17 | |
Profit/Loss From Continuing Operations | 21.37 | 13.07 | 13.22 | 25.38 | 13.17 | |
Profit/Loss For The Period | 21.37 | 13.07 | 13.22 | 25.38 | 13.17 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 70.69 | 43.22 | 43.72 | 83.95 | 43.56 | |
Diluted EPS (Rs.) | 70.69 | 43.22 | 43.72 | 83.95 | 43.56 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.00 | 0.45 | 0.45 | 0.45 | 0.00 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 |
08.09.2025
SMS Lifescience Standalone June 2025 Net Sales at Rs 79.04 crore, down 8.7% Y-o-Y
12.06.2025
SMS Lifescience Standalone March 2025 Net Sales at Rs 85.43 crore, down 1.1% Y-o-Y
04.06.2025
SMS Lifescience Consolidated March 2025 Net Sales at Rs 89.11 crore, down 0.98% Y-o-Y
04.03.2025
SMS Lifescience Consolidated December 2024 Net Sales at Rs 84.60 crore, up 17.41% Y-o-Y
08.09.2025
SMS Lifescience Standalone June 2025 Net Sales at Rs 79.04 crore, down 8.7% Y-o-Y
12.06.2025
SMS Lifescience Standalone March 2025 Net Sales at Rs 85.43 crore, down 1.1% Y-o-Y
04.06.2025
SMS Lifescience Consolidated March 2025 Net Sales at Rs 89.11 crore, down 0.98% Y-o-Y
04.03.2025
SMS Lifescience Consolidated December 2024 Net Sales at Rs 84.60 crore, up 17.41% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017